The Ministry of Commerce and Industry, under the Department for Promotion of Industry and Internal Trade, has introduced draft amendments to the Patents Rules, 2003. These drafts detail various changes proposed by the Central Government, anchored on section 159 of the Patents Act, 1970. The government seeks to amend the …
Driven by efforts to curb fossil-fuel use and concerns about the security of energy supplies, the number of applications for renewable-energy patents is booming. But the patents are scattered across many databases, in different formats that are not readily searchable, leading to a lack of clarity over who owns specific …
THE European Commission has said the proposed free trade agreement (FTA) negotiations with India will not affect production of cheap life-saving medicines in the country.
Prior to the Copenhagen meeting on developing a new framework for climate-change policy there were sharp differences between the positions of developed and developing countries regarding the role of intellectual property rights (IPRs) in fostering international technology transfer (ITT). Expanding effective ITT is central to meeting needs for acquiring and …
Customary land rightsPalm oil firm loses to Kayans A native community in Malaysia won a 12-year legal battle against the Sarawak state government and palm oil giant ioi Pelita after the state’s apex court recognized their customary land rights. The court ruled that the government had unconstitutionally granted the native …
India is expecting a rapid decline in the number of patents claim over its traditional medicinal formulations at the US and UK patents office following TKDL (Traditional Knowledge Digital Library) Access Agreements with these two countries. A recent study carried out by TKDL expert team has revealed a sharp decline …
A GROUP of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some local companies, terming them as frivolous patent claims. The Indian Pharmaceutical Alliance (IPA), whose members include big local players such as Sun Pharma and Dr Reddy
oil exploration Argentine veterans cry war As diplomatic tensions between the UK and Argentina escalate following oil drilling plan near the Falklands, Argentine war veterans have threatened to invade the South Atlantic archipelago controlled by the UK. A war vets’ association in Bruenos Aires demonstrated in front of the British …
GLENMARK Pharmaceuticals said on Monday its unit entered an outof-court settlement with Glaxo-SmithKline LLC over patent actions on doses of atovaquone and proguanil hydrochloride, the generic version of GSK
K P Prabhakaran Nair Monsanto devotes an annual budget of $10 million to harassing, intimidating, suing -and in some cases bankrupting -American farmers over alleged improper use of its patented seeds. This will become the norm for India as well TODAY, Monsanto is the virtual king of genetically modified food …
Civil Society Groups Urge End To India Project, Allege Nexus With MNC Pharma Companies Several civil society groups have come together to question the commerce and industry ministry
TK ARUN STEFAN Oschmann is president, Emerging Markets, at Merck, the world's second largest pharmaceuticals company after its 2009 merger with Schering-Plough, with a combined global revenue in 2009 of $27.4 billion. Now, if that doesn't look very large these days, with the individual worth of each of the top …
GERMAN drugmaker Bayer has filed a patent infringement case against Cipla, the largest domestic drugseller, to stop the Mumbaibased company from selling its generic version of Bayer
Upping the ante in a long-running trade spat with the United States, Brazil announced that it intends to break US patents and intellectual property rights in retaliation against Washington
RANBAXY Laboratories on Monday announced it has settled a patent dispute with Takeda Pharmaceutical allowing the Gurgaon-based drugmaker to launch its generic tablets of Takeda
The Delhi High Court refused a patent linkage to multinational pharma company Bayer’s for its cancer drug sorefenib tosylate, sold under the name Nexavar. This means there is no restriction on the drug controller to approve generic versions of patent drugs. Bayer holds the patent for sorenfenib, used to treat …
Ahmedabad: Leading UK drugmaker AstraZeneca Plc will brand and market 18 medicines manufactured by the Rs 1,600-crore Ahmedabad-based pharma company Torrent Pharmaceuticals in 9 emerging economies. AstraZeneca follows UK peer GlaxoSmithKline Plc and Sanofi-Aventis SA of France in its foray into the growing market for lowerpriced copied medicines as drugmakers …
Chennai: Nearly $60 billion worth of patents for drugs is set to expire in the next four years across the world and Indian pharmaceutical companies are now in a position to take a major share of this pie, industry members said. Already, India is the No. 1 exporter of generic …
